An intervention study of individual, apoe genotype-based dietary and physical-activity advice: Impact on health behavior

Journal of Nutrigenetics and Nutrigenomics

Volumn 7, Issue 3, 2014, Pages 161-174

  Hietaranta Luoma, Hanna Leena ^a,d   Tahvonen, Raija ^b   Iso Touru, Terhi ^b   Puolijoki, Hannu ^c   Hopia, Anu ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b FINNISH FOREST RESEARCH INSTITUTE   (Finland)

^c Southern Ostrobothnia Central Hospital   (United States)

^d Seinäjoki University Hospital and the University Consortium of Seinäjoki   (Finland)

Author keywords

apoE; Dietary advice; Health; Health information; Intervention; Nutrigenomics; Taste attitudes

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; FAT; SATURATED FATTY ACID; UNSATURATED FATTY ACID; APOLIPOPROTEIN E;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR CHANGE; BERRY; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETES MELLITUS; EFFECT SIZE; EXERCISE; FAT INTAKE; FEMALE; GENETIC COUNSELING; GENETIC RISK; GENOTYPE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; INTERVENTION STUDY; LIFESTYLE MODIFICATION; LIPID ABSORPTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF CONCEPT; SINGLE BLIND PROCEDURE; TASTE ATTITUDE SCALE; VEGETABLE; CARDIOVASCULAR DISEASES; COUNSELING; GENETICS; MIDDLE AGED; MOTOR ACTIVITY; PERSONALIZED MEDICINE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; YOUNG ADULT;

ADULT; AGED; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; COUNSELING; FEMALE; GENOTYPE; HEALTH BEHAVIOR; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; MOTOR ACTIVITY; RISK REDUCTION BEHAVIOR; YOUNG ADULT;

EID: 84925445541     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000371743     Document Type: Article

References (36)

1. Smith TW, Orleans CT, Jenkins CD: Prevention and health promotion: decades of progress, new challenges, and an emerging agenda. Health Psychol 2004; 23: 126-131
2. Lovegrove JA, Gitau R: Personalized nutrition for the prevention of cardiovascular disease: a future perspective. J Hum Nutr Diet 2008; 21: 306-316
3. Minich DM, Bland JS: Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations. ScientificWorldJournal 2013; 2013: 129841
4. Görman U, Mathers JC, Grimaldi KA, Ahlgren J, Nordström K: Do we know enough? A scientific and ethical analysis of the basis for genetic-based personalized nutrition. Genes Nutr 2013; 8: 373-381
5. Fishbein M, Cappella JN: The role of theory in developing effective health communications. J Commun 2006; 56:S1-S17
6. Stewart-Knox BJ, Bunting BP, Gilpin S, Parr HJ, Pinhão S, Strain JJ, et al: Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br J Nutr 2009; 101: 982-989
7. Ong TP, Pérusse L: Impact of nutritional epigenomics on disease risk and prevention: introduction. J Nutrigenet Nutrigenomics 2011; 4: 245-247
8. Kang JX: Future directions in nutrition research. J Nutrigenet Nutrigenomics 2013; 6:I-III
9. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, et al: Effects of communicating DNAbased disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 2010; 10:CD007275
10. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC: Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL Study. Alzheimer Dis Assoc Disord 2008; 22: 94-97
11. Marteau T, Senior V, Humphries SE, Bobrow M, Cranston T, Crook MA, et al: Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet A 2004; 128A:285-293
12. Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach G: ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc 2007; 66: 183-197
13. Huebbe P, Lodge JK, Rimbach G: Implications of apolipoprotein E genotype on inflammation and vitamin E status. Mol Nutr Food Res 2010; 54: 623-630
14. Song Y, Stampfer MJ, Liu S: Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004; 141: 137-147
15. Huebbe P, Nebel A, Siegert S, Moehring J, Boesch-Saadatmandi C, Most E, et al: APOE4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 2011; 25: 3262-3270
16. Masson LF, McNeill G, Avenell A: Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 2003; 77: 1098-1111
17. Minihane AM, Khan S, Leigh-Firbank EC, Talmud P, Wright JW, Murphy MC, et al: ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000; 20: 1990-1997
18. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller MJ: Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 2010; 140: 278-284
19. Haddy N, De Bacquer D, Chemaly MM, Maurice M, Ehnholm C, Evans A, et al: The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet 2002; 10: 841-850
20. Witte K, Meyer G, Martell DP: Effective Health Risk Messages: A Step-by-Step Guide. Thousand Oaks, Sage, 2001
21. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
22. Faul F, Erdfelder E, Lang A-G, Buchner A: G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191
23. Helldán A, Helakorpi S, Virtanen S, Uutela A: Suomalaisen aikuisväestön terveyskäyttäytyminen ja terveys, kevät 2012 [Health Behavior and Health among the Finnish Adult Population, Spring 2012]. Helsinki, National Institute for Health and Welfare, 2013
24. Yoon U, Kwok LL, Magkidis A: Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism 2013; 62: 303-314
25. Lehtimäki T, Moilanen T, Viikari J, Akerblom HK, Ehnholm C, Rönnemaa T, et al: Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487-495
26. Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, et al: Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 2000; 152: 475-488
27. Mattisson I, Wirfält E, Aronsson CA, Wallström P, Sonestedt E, Gullberg B, et al: Misreporting of energy: prevalence, characteristics of misreporters and influence on observed risk estimates in the Malmö Diet and Cancer cohort. Br J Nutr 2005; 94: 832-842
28. Yannakoulia M, Panagiotakos DB, Pitsavos C, Stefanadis C: Correlates of BMI misreporting among apparently healthy individuals: the ATTICA study. Obesity (Silver Spring) 2006; 14: 894-901
29. Wetterstrand K: DNA sequencing costs. Data from the NHGRI Genome Sequencing Program (GSP). National Human Genome Research Institute. 2014. https://www.genome.gov/sequencingcosts/
30. Phillips CM: Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 2013; 5: 32-57
31. Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N, et al: Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study. BMJ Open 2014; 4:e004850
32. Finnish Hearth Association: Fat quality of diet. http://www.sydanliitto.fi/etusivu
33. Peltonen M, Harald K, Männistö S, Saarikoski L, Peltomäki P, Lund L, Sundvall J, Juolevi A, Laatikainen T, Aldén-Nieminen H, Luoto R, Jousilahti P, Salomaa V, Taimi M, Vartiainen E: FINRISKI 2007. Helsinki, National Public Health Institute, 2008
34. Saaristo T, Oksa H, Peltonen M, Etu-Seppälä L: FIN-D2D Report. Helsinki, Finnish Diabetes Association, 2009
35. Helakorpi S, Prättälä R, Uutela A: Suomalaisen aikuisväestön terveyskäyttäytyminen ja terveys, kevät 2007 [Health Behavior and Health among the Finnish Adult Population, Spring 2007]. Helsinki, National Institute for Health and Welfare, 2008
36. Roininen K, Tuorila H, Zandstra EH, De Graaf C, Vehkalahti K, Stubenitsky K, et al: Differences in health and taste attitudes and reported behaviour among Finnish, Dutch and British consumers: a cross-national validation of the Health and Taste Attitude Scales (HTAS). Appetite 2001; 37: 33-45.